Republic of the Philippines

Cebu Normal University

Osmeña Blvd., Cebu City, 6000, Philippines

College of Nursing
Telephone No.: (+63 32) 254 4837
Email: cn@cnu.edu.ph
Website: www.cnu.edu.ph

DRUG STUDY

Patient’s Initials: TU Date of Admission: May 10, 2021 Diagnosis: AGE with Mild Dehydration R/I Intestinal Amoebiasis
Age: 15 Height: 60 inches Weight.: 45 kg Clinical Intervention: Administration of Racecadotril (Hidrasec)
Sex: Male Ward: Pedia Bed No.: 3 Name of Physician: Dr. Tan

Drug Information Classification Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities
Generic Name: Pharmacologic Pharmacodynamics or General Contraindicated to (per system preferably) Before Drug Administration:
Racecadotril Classification: Mechanism of Action: Indication: patients with CNS: Headache  Assess patient’s diarrhea.
Antidiarrheal agent Racecadotril is a prodrug Treatment of hypersensitivity to Integumentary: Flushing  Ask patient for current medications taken.
Trade Name: of thiorphan, an acute diarrhea in racecadotril and other of skin, skin rash,  Check doctor’s order.
Hidrasec Therapeutic enkephalinase inhibitor. It adults. ingredients of Hidrasec, swelling, tender red  Observe the 10 rights of drug administration.
Classification: achieves its antisecretory with fructose lumps under the skin, During Drug Administration:
Minimum Dose: Enkephalinase effect by protecting Patient’s intolerance, glucose hives, redness, itching  Administer drug at the right dosage and route
100 mg inhibitor enkephalins from Indication: malabsorption syndrome in the right time.
enzymatic degradation Treatment for or sucrase-isomaltase  Drug must be swallowed with water after
Maximum Dose: thereby prolonging their acute diarrhea. deficiency (granules) meals.
100 mg action at enkephalinergic After drug administration:
synapses in the small  Store this medication at room temperature
Patient’s Dose: intestine and reducing away from moisture and heat.
100 mg/cap hypersecretion.
 Instruct patient to report any adverse
reactions.
Route: Pharmacokinetics:
PO Absorption: Rapidly
absorbed. Time to peak
Frequency: plasma enkephalinase
TID PC meals inhibition: Approx 2
hours.
Availability/Form: Distribution: Plasma
Capsule protein binding: 90%

Certification Date: 1 February 2021

Recertification due date: 24 January 2024
SDF-CON-304-071-00
For verification of the certificate please
access www.gcl-intl.com (Certification Page 1 of 3
check and type the registration number)

This studyRegistration
source was No. 52Q18778
downloaded by 100000765066348 from CourseHero.com on 04-03-2023 05:47:58 GMT -05:00
 Republic of the Philippines
Cebu Normal University
Osmeña Blvd., Cebu City, 6000, Philippines

College of Nursing
Telephone No.: (+63 32) 254 4837
Email: cn@cnu.edu.ph
Website: www.cnu.edu.ph

Contents: (mainly albumin).

Racecadotril, lactose Metabolism: Rapidly
monohydrate, hydrolysed to thiorphan,
pregelatinised maize the active metabolite,
starch, magnesium which is in turn
stearate and transformed to inactive
colloidal anhydrous metabolites.
silica. The capsule Excretion: Mainly via
contains gelatin, urine (81.4%), via faeces
yellow iron oxide (approx 8%). Elimination
(E172) and titanium half-life: Approx 3-4
dioxide (E171) hours.

References (at least 2):

HIDRASEC 100 MG HARD CAPSULES. Drugs.com. (n.d.). https://www.drugs.com/uk/hidrasec-100-mg-hard-capsules-leaflet.html.
Team, C. by M. I. M. S. O. (n.d.). Racecadotril. Racecadotril: Indication, Dosage, Side Effect, Precaution | MIMS Philippines. https://www.mims.com/philippines/drug/info/racecadotril/.

PRODUCT ASSESSMENT RUBRICS FOR DRUG STUDY

Student Name: Therese Anne Densing Year/Section: BSN-2B Date: May 10 2021 Score: ___/30

Directions: Please select the appropriate rating using the following descriptions.

Element Very Satisfactory Satisfactory Needs Improvement Comments

Certification Date: 1 February 2021

Recertification due date: 24 January 2024
SDF-CON-304-071-00
For verification of the certificate please
access www.gcl-intl.com (Certification Page 2 of 3
check and type the registration number)

This studyRegistration
source was No. 52Q18778
downloaded by 100000765066348 from CourseHero.com on 04-03-2023 05:47:58 GMT -05:00
 Republic of the Philippines
Cebu Normal University
Osmeña Blvd., Cebu City, 6000, Philippines

College of Nursing
Telephone No.: (+63 32) 254 4837
Email: cn@cnu.edu.ph
Website: www.cnu.edu.ph

Drug ☐ Accurately presented all of the patient and drug information ☐ Accurately presented most of the patient and drug ☐ Accurately presented some of the patient and drug information
Information (name [brand & generic], dosage [patient’s dose; min. & max], information related to the case. 1 missing information or error related to the case. 2 or more missing information or errors noted.
(10%) frequency, route, availability, contents) related to the case. [3] noted. [2] [1]

Classification ☐ Accurately presented the classification (therapeutic and ☐ Accurately presented the classification related to the drug ☐ Inaccurately presented the classification related to the drug.
(10%) pharmacologic) related to the drug. [3] but with 1 irrelevant information or error noted. [2] Classification is not relevant to the drug. [1]

☐ Accurately presented the indication/s (general & patient- ☐ Accurately presented the indication/s related to the drug but ☐ Inaccurately presented the indication/s related to the drug.
Indication (10%)
specific) related to the drug. [3] with 1 irrelevant information or error noted. [2] Indication is not relevant to the drug. [1]
Mechanism of ☐ Accurately presented the mechanism of action ☐ Accurately presented the mechanism of action of the drug ☐ Inaccurately presented the mechanism of action of the drug.
Action (10%) (pharmacokinetics, pharmacodynamics) of the drug. [3] but with 1 irrelevant information or error noted. [2] Mechanism of action is not relevant to the drug. [1]
☐ Accurately presented all of the common contraindications ☐ Accurately presented most of the common contraindications ☐ Accurately presented some of the common contraindications
Contraindication related to the drug. [3] related to the drug. 1 missing information or error noted. [2] related to the drug. 2 or more missing information or errors noted.
(10%) [1]
Side Effects ☐ Accurately presented all of the common side effects related to ☐ Accurately presented most of the common side effects ☐ Accurately presented some of the common side effects related
(10%) the drug. [3] related to the drug. 1-2 missing information or errors noted. [2] to the drug. 3 or more missing information or errors noted. [1]
Nursing ☐ Accurately presented all of the common nursing ☐ Accurately presented most of the common nursing ☐ Accurately presented some of the common nursing
Responsibilities responsibilities (before, during, and after) related to the drug. [9] responsibilities related to the drug. 1-2 missing information or responsibilities related to the drug. 3 or more missing information
(30%) errors noted. [7] or errors noted. [3]
☐ Presented at least 2 sources that are updated (within 5 years), ☐ Presented only one source that is updated (within 5 years), ☐ No source was presented. Sources are not updated (more than 5
References
relevant, and credible. [3] relevant, and credible. Other sources are not updated, credible years), relevant, and credible. [1]
(10%) or relevant. [2]
Sub-score = ____ = ____ = ____

Evaluated by:
_______________________________________
Signature over Printed Name of Clinical Instructor

Certification Date: 1 February 2021

Recertification due date: 24 January 2024
SDF-CON-304-071-00
For verification of the certificate please
access www.gcl-intl.com (Certification Page 3 of 3
check and type the registration number)

This studyRegistration
source was No. 52Q18778
downloaded by 100000765066348 from CourseHero.com on 04-03-2023 05:47:58 GMT -05:00
Powered by TCPDF (www.tcpdf.org)